ArticleJournal of neurology2022

Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.

Alessandro Miscioscia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.